Q92597 (NDRG1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 117.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Protein NDRG1 Alternative name(s): Differentiation-related gene 1 protein Short name=DRG-1 N-myc downstream-regulated gene 1 protein Nickel-specific induction protein Cap43 Reducing agents and tunicamycin-responsive protein Short name=RTP Rit42 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 394 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Stress-responsive protein involved in hormone responses, cell growth, and differentiation. Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53-mediated caspase activation and apoptosis. Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy. Ref.11 Ref.15 Ref.16 Ref.18 Ref.23 |
| Subunit structure | Interacts with RAB4A (membrane-bound form); the interaction involves NDRG1 in vesicular recycling of CDH1. Ref.18 Ref.23 |
| Subcellular location | Cytoplasm › cytosol. Cytoplasm › cytoskeleton › centrosome. Nucleus. Cell membrane. Note: Mainly cytoplasmic but differentially localized to other regions. Associates with the plasma membrane in intestinal epithelia and lactating mammary gland. Translocated to the nucleus in a p53/TP53-dependent manner. In prostate epithelium and placental chorion, located in both the cytoplasm and in the nucleus. No nuclear localization in colon epithelium cells. In intestinal mucosa, prostate and renal cortex, located predominantly adjacent to adherens junctions. Cytoplasmic with granular staining in proximal tubular cells of the kidney and salivary gland ducts. Recruits to the membrane of recycling/sorting and late endosomes via binding to phosphatidylinositol 4-phosphate. Associates with microtubules. Colocalizes with TUBG1 in the centrosome. Cytoplasmic location increased with hypoxia. Phosphorylated form found associated with centromeres during S-phase of mitosis and with the plasma membrane. Ref.2 Ref.13 Ref.14 Ref.15 Ref.22 Ref.23 Ref.29 |
| Tissue specificity | Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Also expressed in heart, brain, skeletal muscle, lung, liver and pancreas. Low levels in peripheral blood leukocytes and in tissues of the immune system. Expressed mainly in epithelial cells. Also found in Schwann cells of peripheral neurons. Reduced expression in adenocarcinomas compared to normal tissues. In colon, prostate and placental membranes, the cells that border the lumen show the highest expression. Ref.1 Ref.2 Ref.3 Ref.14 |
| Induction | By homocysteine, 2-mercaptoethanol, tunicamycin in endothelial cells. Induced approximately 20-fold during in vitro differentiation of the colon carcinoma cell lines HT29-D4 and Caco-2. Induced by oxidative stress in colon cancers. Decreased expression in colon adenomas and adenocarcinomas. Induced by nickel compounds in all tested cell lines. The primary signal for its induction is an elevation of free intracellular calcium ion caused by nickel ion exposure. Okadaic acid, a serine/threonine phosphatase inhibitor, induced its expression more rapidly and more efficiently than nickel. Ref.1 Ref.2 Ref.3 Ref.4 Ref.11 Ref.22 |
| Post-translational modification | Under stress conditions, phosphorylated in the C-terminal on many serine and threonine residues. Phosphorylated in vitro by PKA. Phosphorylation enhanced by increased intracellular cAMP levels. Homocysteine induces dephosphorylation. Phosphorylation by SGK1 is cell cycle dependent. Ref.13 Ref.17 Ref.19 Ref.20 Ref.21 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28 Ref.29 |
| Involvement in disease | Defects in NDRG1 are the cause of Charcot-Marie-Tooth disease type 4D (CMT4D) [MIM:601455]; also known as hereditary motor and sensory neuropathy Lom type (HMSNL). CMT4D is a recessive form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy and primary peripheral axonal neuropathy. Demyelinating CMT neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention, autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. Ref.12 |
| Sequence similarities | Belongs to the NDRG family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CANX | P27824 | 2 | EBI-716486,EBI-355947 | |
| XRCC6 | P12956 | 2 | EBI-716486,EBI-353208 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 394 | 394 | Protein NDRG1 | PRO_0000159573 | |||||
Regions | |||||||||
| Repeat | 339 – 348 | 10 | 1 | ||||||
| Repeat | 349 – 358 | 10 | 2 | ||||||
| Repeat | 359 – 368 | 10 | 3 | ||||||
| Region | 339 – 368 | 30 | 3 X 10 AA tandem repeats of G-T-R-S-R-S-H-T-S-E | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 319 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 326 | 1 | Phosphoserine Ref.19 Ref.24 | ||||||
| Modified residue | 328 | 1 | Phosphothreonine Ref.19 Ref.24 Ref.28 | ||||||
| Modified residue | 330 | 1 | Phosphoserine; by SGK1 Ref.17 Ref.19 Ref.20 Ref.24 Ref.25 Ref.28 | ||||||
| Modified residue | 332 | 1 | Phosphoserine; by SGK1 Ref.24 Ref.25 | ||||||
| Modified residue | 333 | 1 | Phosphoserine Ref.24 Ref.25 Ref.28 | ||||||
| Modified residue | 335 | 1 | Phosphothreonine Ref.24 Ref.25 | ||||||
| Modified residue | 336 | 1 | Phosphoserine Ref.17 Ref.24 | ||||||
| Modified residue | 346 | 1 | Phosphothreonine; by SGK1 Ref.27 | ||||||
| Modified residue | 356 | 1 | Phosphothreonine; by SGK1 Ref.27 | ||||||
| Modified residue | 362 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 364 | 1 | Phosphoserine; by SGK1 Ref.24 Ref.25 Ref.26 | ||||||
| Modified residue | 366 | 1 | Phosphothreonine Ref.21 Ref.27 | ||||||
| Modified residue | 375 | 1 | Phosphothreonine Ref.24 | ||||||
Natural variations | |||||||||
| Natural variant | 67 | 1 | M → V. Corresponds to variant rs2233319 [ dbSNP | Ensembl ]. | VAR_050234 | |||||
| Natural variant | 111 | 1 | M → L. Corresponds to variant rs2233328 [ dbSNP | Ensembl ]. | VAR_050235 | |||||
Experimental info | |||||||||
| Sequence conflict | 145 | 1 | I → T in CAA63430. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes." Kokame K., Kato H., Miyata T. J. Biol. Chem. 271:29659-29665(1996) [PubMed: 8939898] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, TISSUE SPECIFICITY. Tissue: Umbilical vein endothelial cell. |
| [2] | "A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms." van Belzen N., Dinjens W.N.M., Diesveld M.P.G., Groen N.A., van der Made A.C.J., Nozawa Y., Vlietstra R., Trapman J., Bosman F.T. Lab. Invest. 77:85-92(1997) [PubMed: 9251681] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [3] | "Cap43, a novel gene specifically induced by Ni2+ compounds." Zhou D., Salnikow K., Costa M. Cancer Res. 58:2182-2189(1998) [PubMed: 9605764] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION. Tissue: Lung. |
| [4] | "Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells." Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., Commes T. Biochim. Biophys. Acta 1450:364-373(1999) [PubMed: 10395947] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INDUCTION. |
| [5] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [7] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed: 16421571] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [9] | Angelicheva D., Kalaydjieva L. Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-21. Tissue: Brain. |
| [10] | Lubec G., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 4-19; 54-70; 133-148; 199-212; 286-300; 307-322; 328-341 AND 364-388, MASS SPECTROMETRY. Tissue: Fetal brain cortex. |
| [11] | "Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage." Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., Lee S.W. Cancer Res. 58:4439-4444(1998) [PubMed: 9766676] [Abstract] Cited for: FUNCTION, INDUCTION. |
| [12] | "N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom." Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F., de Jonge R., Blechschmidt K., Angelicheva D., Chandler D., Worsley P., Rosenthal A., King R.H.M., Thomas P.K. Am. J. Hum. Genet. 67:47-58(2000) [PubMed: 10831399] [Abstract] Cited for: INVOLVEMENT IN CMT4D. |
| [13] | "Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein." Agarwala K.L., Kokame K., Kato H., Miyata T. Biochem. Biophys. Res. Commun. 272:641-647(2000) [PubMed: 10860807] [Abstract] Cited for: PHOSPHORYLATION, SUBCELLULAR LOCATION. |
| [14] | "Expression of NDRG1, a differentiation-related gene, in human tissues." Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., Bosman F.T. Histochem. Cell Biol. 118:399-408(2002) [PubMed: 12432451] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [15] | "Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint." Kim K.T., Ongusaha P.P., Hong Y.K., Kurdistani S.K., Nakamura M., Lu K.P., Lee S.W. J. Biol. Chem. 279:38597-38602(2004) [PubMed: 15247272] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [16] | "NDRG1 is necessary for p53-dependent apoptosis." Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V., Jackson R.S. II, Wang M., Liang P. J. Biol. Chem. 279:48930-48940(2004) [PubMed: 15377670] [Abstract] Cited for: FUNCTION. |
| [17] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319; SER-330 AND SER-336, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24." Hunter M., Angelicheva D., Tournev I., Ingley E., Chan D.C., Watts G.F., Kremensky I., Kalaydjieva L. Biochem. Biophys. Res. Commun. 332:982-992(2005) [PubMed: 15922294] [Abstract] Cited for: INTERACTION WITH APOA1; APOA2; PRA1 AND RTN1, POSSIBLE FUNCTION. |
| [19] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; THR-328 AND SER-330, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [21] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366, MASS SPECTROMETRY. Tissue: Prostate cancer. |
| [22] | "Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma." Sibold S., Roh V., Keogh A., Studer P., Tiffon C., Angst E., Vorburger S.A., Weimann R., Candinas D., Stroka D. FEBS Lett. 581:989-994(2007) [PubMed: 17316623] [Abstract] Cited for: SUBCELLULAR LOCATION, INDUCTION. |
| [23] | "The N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin." Kachhap S.K., Faith D., Qian D.Z., Shabbeer S., Galloway N.L., Pili R., Denmeade S.R., DeMarzo A.M., Carducci M.A. PLoS ONE 2:E844-E844(2007) [PubMed: 17786215] [Abstract] Cited for: INTERACTION WITH RAB4A, SUBCELLULAR LOCATION, FUNCTION. |
| [24] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; THR-328; SER-330; SER-332; SER-333; THR-335; SER-336; SER-364 AND THR-375, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [25] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330; SER-332; SER-333; THR-335 AND SER-364, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [26] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, MASS SPECTROMETRY. |
| [27] | "SGK1 activity in Na+ absorbing airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation." Inglis S.K., Gallacher M., Brown S.G., McTavish N., Getty J., Husband E.M., Murray J.T., Wilson S.M. Pflugers Arch. 457:1287-1301(2009) [PubMed: 18787837] [Abstract] Cited for: PHOSPHORYLATION AT THR-346; THR-356 AND THR-366. |
| [28] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328; SER-330 AND SER-333, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [29] | "Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle." McCaig C., Potter L., Abramczyk O., Murray J.T. Biochem. Biophys. Res. Commun. 411:227-234(2011) [PubMed: 21708134] [Abstract] Cited for: PHOSPHORYLATION, SUBCELLULAR LOCATION. |
| [30] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | D87953 mRNA. Translation: BAA13505.1. X92845 mRNA. Translation: CAA63430.1. AF004162 mRNA. Translation: AAC13419.1. AF186190 Genomic DNA. No translation available. CR456842 mRNA. Translation: CAG33123.1. AK126924 mRNA. Translation: BAG54400.1. AF192304 Genomic DNA. No translation available. BC003175 mRNA. Translation: AAH03175.1. AF230380 mRNA. Translation: AAF71305.1. |
| IPI | IPI00022078. |
| RefSeq | NP_001128714.1. NM_001135242.1. NP_006087.2. NM_006096.3. |
| UniGene | Hs.372914. Hs.618002. |
3D structure databases | |
| ProteinModelPortal | Q92597. |
| SMR | Q92597. Positions 32-316. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q92597. 64 interactions. |
| STRING | Q92597. |
Protein family/group databases | |
| MEROPS | S33.988. |
PTM databases | |
| PhosphoSite | Q92597. |
Polymorphism databases | |
| DMDM | 6166568. |
Proteomic databases | |
| PRIDE | Q92597. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000323851; ENSP00000319977; ENSG00000104419. ENST00000414097; ENSP00000404854; ENSG00000104419. |
| GeneID | 10397. |
| KEGG | hsa:10397. |
| UCSC | uc003yug.1. human. |
Organism-specific databases | |
| CTD | 10397. |
| GeneCards | GC08M134318. |
| H-InvDB | HIX0019763. |
| HGNC | HGNC:7679. NDRG1. |
| HPA | HPA006881. |
| MIM | 601455. phenotype. 605262. gene. |
| neXtProt | NX_Q92597. |
| Orphanet | 99950. Charcot-Marie-Tooth disease type 4D. |
| PharmGKB | PA31482. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG15489. |
| GeneTree | ENSGT00390000001874. |
| HOGENOM | HBG445737. |
| HOVERGEN | HBG052591. |
| InParanoid | Q92597. |
| OMA | QEQDIET. |
| PhylomeDB | Q92597. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | hif1_tfpathway. HIF-1-alpha transcription factor network. |
Gene expression databases | |
| ArrayExpress | Q92597. |
| Bgee | Q92597. |
| CleanEx | HS_DRG1. HS_NDRG1. |
| Genevestigator | Q92597. |
| GermOnline | ENSG00000104419. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR004142. Ndr. [Graphical view] |
| PANTHER | PTHR11034. Ndr. 1 hit. |
| Pfam | PF03096. Ndr. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 39394. |
| SOURCE | Search... |
Entry information
| Entry name | NDRG1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92597 Secondary accession number(s): O15207 Q9UK29 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with